These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2960274)

  • 1. Testing of controlled-release transdermal dosage forms. Product development and clinical trials.
    Shaw JE; Prevo ME; Amkraut AA
    Arch Dermatol; 1987 Nov; 123(11):1548-56. PubMed ID: 2960274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal drug delivery: a review of pharmaceutics, pharmacokinetics, and pharmacodynamics.
    Moore L; Chien YW
    Crit Rev Ther Drug Carrier Syst; 1988; 4(4):285-349. PubMed ID: 3133121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal therapeutic systems and rate controlled drug delivery.
    Yum SI
    Med Prog Technol; 1989; 15(1-2):47-52. PubMed ID: 2530425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Your CE topic (No. 111). Clinical application of transdermal drug delivery systems (Part II).
    Lackner TE
    J Pract Nurs; 1990 Mar; 40(1):42-50. PubMed ID: 2109799
    [No Abstract]   [Full Text] [Related]  

  • 5. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute.
    Wokovich AM; Prodduturi S; Doub WH; Hussain AS; Buhse LF
    Eur J Pharm Biopharm; 2006 Aug; 64(1):1-8. PubMed ID: 16797171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-layer weekly sustained release transdermal patch containing gestodene and ethinylestradiol.
    Gao Y; Liang J; Liu J; Xiao Y
    Int J Pharm; 2009 Jul; 377(1-2):128-34. PubMed ID: 19463930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kinetics of a new patch for transdermal administration of 17 beta-estradiol].
    Rohr UD; Nauert C; Ehrly AM
    Zentralbl Gynakol; 1995; 117(10):531-9. PubMed ID: 7491836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation development, in vitro and in vivo evaluation of membrane controlled transdermal systems of glibenclamide.
    Mutalik S; Udupa N
    J Pharm Pharm Sci; 2005 Jan; 8(1):26-38. PubMed ID: 15946595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation and evaluation in vivo and in vitro of glimepiride gel-matrix controlled-release patch].
    Zhang Y; Xu DH; Ma Z; Chen Y; Zhao JJ; Xu SB
    Yao Xue Xue Bao; 2004 Aug; 39(8):640-4. PubMed ID: 15563069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transdermal therapeutic systems (TTS)].
    Niedner R
    Hautarzt; 1988 Dec; 39(12):761-6. PubMed ID: 2976752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergic contact dermatitis from transdermal estradiol and systemic contact dermatitis from oral estradiol. A case report.
    Corazza M; Mantovani L; Montanari A; Virgili A
    J Reprod Med; 2002 Jun; 47(6):507-9. PubMed ID: 12092023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of occlusion of the skin with transdermal therapeutic system on Langerhans' cells and the induction of skin irritation.
    Nieboer C; Bruynzeel DP; Boorsma DM
    Arch Dermatol; 1987 Nov; 123(11):1499-502. PubMed ID: 2960271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo evaluation of a theophylline oral controlled-release unit dosage form.
    Gangadharan B; Ritschel WA; Hussain SA
    Arzneimittelforschung; 1987 Nov; 37(11):1256-7. PubMed ID: 3440033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the clinical effectiveness and adverse effects of transdermal nitroglycerin in the form of plasters in patients with stable coronary disease].
    Kośmicki M; Sadowski Z
    Kardiol Pol; 1988; 31(12):758-65. PubMed ID: 3151499
    [No Abstract]   [Full Text] [Related]  

  • 15. The isolated normothermic hemoperfused porcine forelimb as a test system for transdermal absorption studies.
    Wagner SM; Nogueira AC; Paul M; Heydeck D; Klug S; Christ B
    J Artif Organs; 2003; 6(3):183-91. PubMed ID: 14598102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal drug delivery: clinical considerations for the obstetrician-gynecologist.
    Potts RO; Lobo RA
    Obstet Gynecol; 2005 May; 105(5 Pt 1):953-61. PubMed ID: 15863530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal delivery of drugs.
    Brown L; Langer R
    Annu Rev Med; 1988; 39():221-9. PubMed ID: 3130771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transdermal therapeutic systems for drug administration].
    Hupfeld S; Gravem H
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):532-3. PubMed ID: 19282891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models.
    Godin B; Touitou E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1152-61. PubMed ID: 17889400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical development and clinical effectiveness of a novel gel technology for transdermal drug delivery.
    Alberti I; Grenier A; Kraus H; Carrara DN
    Expert Opin Drug Deliv; 2005 Sep; 2(5):935-50. PubMed ID: 16296788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.